rs1057520085
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001173990.3(TMEM216):c.35-13_36delGCTCCTTTTTCAGGT(p.Gly12fs) variant causes a frameshift, splice acceptor, splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000522 in 1,531,520 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G12G) has been classified as Likely benign.
Frequency
Consequence
NM_001173990.3 frameshift, splice_acceptor, splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- Joubert syndrome 2Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome type 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMEM216 | ENST00000515837.7 | c.35-15_35-1delGTGCTCCTTTTTCAG | splice_acceptor_variant, splice_region_variant, intron_variant | Intron 1 of 4 | 2 | NM_001173990.3 | ENSP00000440638.1 | |||
| TMEM216 | ENST00000334888.10 | c.35-15_35-1delGTGCTCCTTTTTCAG | splice_acceptor_variant, splice_region_variant, intron_variant | Intron 1 of 4 | 2 | ENSP00000334844.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152212Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000735 AC: 1AN: 136096 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000508 AC: 7AN: 1379308Hom.: 0 AF XY: 0.00000441 AC XY: 3AN XY: 680914 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
Joubert syndrome 2 Pathogenic:2
- -
- -
Joubert syndrome 2;C1864148:Meckel syndrome, type 2 Pathogenic:1
- -
Joubert syndrome Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant results in the deletion of part of exon 2 (c.35-13_36del) of the TMEM216 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TMEM216 are known to be pathogenic (PMID: 20512146). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with TMEM216-related conditions. ClinVar contains an entry for this variant (Variation ID: 376902). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at